Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

DESIGN AND IMMUNOGENICITY OF V3-GLYCAN EPITOPE-FOCUSED NANOPARTICLES FOR HIV VACCINES

By Jimmy He PharmD, DScApril 22, 2021

…ferritin nanoparticles. A single boost elicited antibodies with preferential binding to the glycopeptide versus the aglycone peptide. A second boost increased glycopeptide binding, but also induced V3 peptide-specific antibodies. Boosting…

IMMUNOAGONIST CONVERTS CMV-SPECIFIC T CELLS INTO MORE POTENT HIV-SPECIFIC CAR-T CELLS

By Jimmy He PharmD, DScApril 4, 2022

…MHC molecules covalently-tethered to a virus-derived peptide enabling delivery of TCR-specific and costimulatory signals to antigen-specific T cells. We hypothesized that synTac-activation of virus-specific effector-memory CD8+ T cells would selectively…

STRUCTURE AND MECHANISM OF VPS4, THE ENZYME THAT DRIVES HIV BUDDING

By Enthusiast Inc MDMarch 5, 2018

…Å resolution cryo-EM structure of the active Vps4 hexamer in complex with its cofactor Vta1, ADP·BeFx, and an ESCRT-III substrate peptide. Five Vps4 subunits form a helix, with interfaces between…

405 – Robust CD8+ T-Cell Proliferation and Stem-Like Memory Phenotype Linked to HIV Post-Treatment Control

By Jimmy He PharmD, DScMarch 20, 2025

…of these responses. Methods We evaluated HIV-specific CD8+ T cell responses of 6 PTCs, in comparison to 6 previously ART-treated spontaneous controllers (TCs) and 11 non-controllers (NCs), both pre- and…

THE THERAPEUTIC VACCINE VACC-4X TARGETS GAG CTL EPITOPES WITH PREEXISTING MUTATIONS

By Enthusiast Inc MDMarch 5, 2018

Therapeutic HIV immunisation followed by latency reversal has been suggested as a strategy to achieve a functional cure for HIV. The efficacy of a therapeutic peptide vaccine to improve antiviral…

CONSERVED CSF HIV ANTIBODY RESPONSE IN PATIENTS WITH DIVERSE NEUROLOGIC PHENOTYPES

By Jimmy He PharmD, DScApril 28, 2020

…phage were immunoprecipitated and after two rounds of enrichment, were deep sequenced to quantify enriched viral peptides. Separately, unbiased metagenomic next-generation sequencing (mNGS) of total CSF RNA was performed to…

Characterising the Complex Mutational Pathways Associated With Maraviroc-Resistant HIV-1

By Enthusiast Inc MDSeptember 29, 2014

…is to understand the R5 resistance pathway in a comprehensive way based on envelope sequence data. Methodology: We use population genetic, coevolutionary, recombination, positive selection and structural analysis to analyse…

COMBINATION OF IMMUNE CHECKPOINT BLOCKADE INCREASES IL-2 IN HIV-SPECIFIC T CELLS

By Jimmy He PharmD, DScApril 22, 2021

…with anti-TIGIT (median fold change, FC compared to isotype controls 1.75x) and anti-CTLA-4 (median FC 1.38x) in HIV-specific CD4+ T cells. We also observed increased frequency of cells expressing IL-2…

410 – Oxidative Stress-Mediated CTL Susceptibility in Reservoir Clones Despite Limited Antigen Expression

By Jimmy He PharmD, DScMarch 31, 2026

…marked by BCL-2, cytotoxic gene overexpression and metabolic quiescence. Here, we demonstrate metabolic quiescence and low oxidative stress as a mechanism of resistance in authentic reservoir clones (ARCs). Methods ARCs…

COMPARING THE CHARACTERISTICS OF BRAZILIAN MSM USING APP FOR SEXUAL ENCOUNTERS

By Enthusiast Inc MDMarch 5, 2018

Geosocial networking (GSN) smartphone applications (apps) are becoming the main venue for sexual encounters among Brazilian men who have sex with men (MSM). As HIV infection risk has been increasing…

←1
234567891011121314151617181920212223242526272829303132
…3334353637…
383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top